Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors-Reference-Cited by-同舟云学术

Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors

Published:2020-07-22 Issue:18 Volume:9 Page:6485-6496
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Shen Yan‐Ying¹²,Ma Xin‐Li¹,Wang Ming¹,Zhuang Chun¹,Ni Bo¹^ORCID,Tu Lin¹,Liu Qiang²,Zhao Wen‐Yi¹,Cao Hui¹

Affiliation:

1. Department of Gastrointestinal Surgery Renji HospitalSchool of MedicineShanghai Jiaotong University Shanghai P.R. China

2. Department of Pathology Renji HospitalSchool of MedicineShanghai Jiaotong University Shanghai P.R. China

Funder

Medical and Engineering Cross Research Foundation of Shanghai Jiaotong University

Project of Shanghai Municipal Health Commission

Clinical Research Plan of Shanghai Hospital Development Center

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3212

Reference17 articles.

1. Gastrointestinal stromal tumours: origin and molecular oncology

2. Gastrointestinal stromal tumors: Pathology and prognosis at different sites

3. Risk stratification of patients diagnosed with gastrointestinal stromal tumor

4. Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications

5. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular pathology of gastrointestinal stromal tumors;Diagnostic Molecular Pathology;2024

2. Clinical-radiomics-based treatment decision support for KIT Exon 11 deletion in gastrointestinal stromal tumors: a multi-institutional retrospective study;Frontiers in Oncology;2023-08-14

3. The role of genetic testing in the prognosis and management of solid tumors. A literature review;Revista Romana de Medicina de Laborator;2023-07-01

4. Undetected KIT and PDGFRA mutations: an under-recognised cause of gastrointestinal stromal tumours (GISTs) incorrectly classified as wild-type;Pathology;2023-02

5. PATIENT MANAGEMENT TACTICS AT DIFFERENT STAGES OF GASTROINTESTINAL STROMAL TUMORS (GIST);Wiadomości Lekarskie;2023